Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-05-016688
Filing Date
2005-04-15
Accepted
2005-04-15 16:23:36
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a05-4705_110ka.htm 10-K/A 1486064
2 EX-21 a05-4705_1ex21.htm EX-21 8520
3 EX-23.1 a05-4705_1ex23d1.htm EX-23.1 4738
4 EX-23.2 a05-4705_1ex23d2.htm EX-23.2 2192
5 EX-31.1 a05-4705_1ex31d1.htm EX-31.1 9379
6 EX-31.2 a05-4705_1ex31d2.htm EX-31.2 9455
7 EX-32 a05-4705_1ex32.htm EX-32 7070
8 GRAPHIC g47051fbimage002.gif GRAPHIC 727
  Complete submission text file 0001104659-05-016688.txt   1530044
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-13341 | Film No.: 05753963
SIC: 2836 Biological Products, (No Diagnostic Substances)